These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22650169)

  • 21. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychology and epilepsy].
    Campos-Castelló J; Campos-Soler S
    Rev Neurol; 2004 Jul 16-31; 39(2):166-77. PubMed ID: 15264168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical properties of antiepileptic drugs (AEDs).
    Bialer M
    Adv Drug Deliv Rev; 2012 Jul; 64(10):887-95. PubMed ID: 22210279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
    Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
    Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy.
    Moavero R; Santarone ME; Galasso C; Curatolo P
    Brain Dev; 2017 Jun; 39(6):464-469. PubMed ID: 28202262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.
    Faulkner MA; Burke RA
    Expert Opin Drug Saf; 2013 Nov; 12(6):847-55. PubMed ID: 23883095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive, affective, and behavioral side events in adults secondary to antiepileptic drug use.
    Mattson RH
    Rev Neurol Dis; 2004; 1 Suppl 1():S10-7. PubMed ID: 16400290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of antiepileptics drugs on cognition].
    Aldenkamp AP; Vermeulen J
    Rev Neurol; 2002 May 1-15; 34(9):851-6. PubMed ID: 12134350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems in the assessment of cognitive effects of antiepileptic drugs.
    Dodrill CB
    Epilepsia; 1992; 33 Suppl 6():S29-32. PubMed ID: 1486833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epilepsy, anticonvulsant drugs and cognition.
    Drane DL; Meador KJ
    Baillieres Clin Neurol; 1996 Dec; 5(4):877-85. PubMed ID: 9068886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
    IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
    Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
    Gunthorpe MJ; Large CH; Sankar R
    Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
    Novy J; Patsalos PN; Sander JW; Sisodiya SM
    Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacosamide in patients with pharmacoresistant epilepsy.
    Verrotti A; Loiacono G; Olivieri C; Zulli E; Zaccara G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2065-72. PubMed ID: 22873760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cognitive effects of antiepileptic drugs].
    Malagón-Valdez J
    Rev Neurol; 2003 Feb 1-15; 36(3):288-92. PubMed ID: 12599162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
    Splinter MY
    Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The neuropsychology of epilepsy: what factors are involved?].
    Campos-Castello J
    Rev Neurol; 2006 Oct; 43 Suppl 1():S59-70. PubMed ID: 17061199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive effects of GABAergic antiepileptic drugs.
    Czubak A; Nowakowska E; Burda K; Kus K; Metelska J
    Arzneimittelforschung; 2010; 60(1):1-11. PubMed ID: 20184221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.